杏林製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/02/14 | 1,393 | 1,394 | 1,380 | 1,386 | -1 | -0.1% | 51,400 |
| 2025/02/13 | 1,371 | 1,393 | 1,371 | 1,387 | +25 | +1.8% | 69,800 |
| 2025/02/12 | 1,397 | 1,397 | 1,362 | 1,362 | -22 | -1.6% | 122,900 |
| 2025/02/10 | 1,387 | 1,388 | 1,376 | 1,384 | +11 | +0.8% | 57,100 |
| 2025/02/07 | 1,385 | 1,401 | 1,371 | 1,373 | -10 | -0.7% | 151,500 |
| 2025/02/06 | 1,400 | 1,400 | 1,376 | 1,383 | -39 | -2.7% | 240,300 |
| 2025/02/05 | 1,430 | 1,439 | 1,422 | 1,422 | -7 | -0.5% | 118,400 |
| 2025/02/04 | 1,435 | 1,446 | 1,428 | 1,429 | +1 | +0.1% | 75,500 |
| 2025/02/03 | 1,462 | 1,466 | 1,424 | 1,428 | -44 | -3% | 200,500 |
| 2025/01/31 | 1,473 | 1,473 | 1,464 | 1,472 | -2 | -0.1% | 66,400 |
| 2025/01/30 | 1,463 | 1,474 | 1,460 | 1,474 | +6 | +0.4% | 80,900 |
| 2025/01/29 | 1,470 | 1,473 | 1,463 | 1,468 | -4 | -0.3% | 45,400 |
| 2025/01/28 | 1,470 | 1,482 | 1,462 | 1,472 | +1 | +0.1% | 49,700 |
| 2025/01/27 | 1,457 | 1,472 | 1,457 | 1,471 | +14 | +1% | 46,100 |
| 2025/01/24 | 1,445 | 1,457 | 1,443 | 1,457 | +17 | +1.2% | 83,400 |
| 2025/01/23 | 1,442 | 1,443 | 1,435 | 1,440 | ±0 | ±0% | 70,900 |
| 2025/01/22 | 1,450 | 1,451 | 1,440 | 1,440 | -2 | -0.1% | 52,700 |
| 2025/01/21 | 1,451 | 1,454 | 1,442 | 1,442 | ±0 | ±0% | 32,700 |
| 2025/01/20 | 1,441 | 1,455 | 1,441 | 1,442 | +2 | +0.1% | 36,000 |
| 2025/01/17 | 1,444 | 1,445 | 1,437 | 1,440 | -6 | -0.4% | 61,200 |
| 2025/01/16 | 1,450 | 1,454 | 1,445 | 1,446 | -4 | -0.3% | 66,000 |
| 2025/01/15 | 1,446 | 1,453 | 1,445 | 1,450 | +1 | +0.1% | 57,300 |
| 2025/01/14 | 1,450 | 1,453 | 1,439 | 1,449 | -5 | -0.3% | 82,800 |
| 2025/01/10 | 1,462 | 1,462 | 1,452 | 1,454 | -8 | -0.5% | 38,200 |
| 2025/01/09 | 1,480 | 1,480 | 1,462 | 1,462 | -19 | -1.3% | 72,900 |
| 2025/01/08 | 1,499 | 1,501 | 1,481 | 1,481 | -23 | -1.5% | 61,800 |
| 2025/01/07 | 1,510 | 1,510 | 1,491 | 1,504 | +1 | +0.1% | 73,600 |
| 2025/01/06 | 1,505 | 1,507 | 1,495 | 1,503 | -2 | -0.1% | 92,000 |
| 2024/12/30 | 1,498 | 1,518 | 1,497 | 1,505 | +19 | +1.3% | 107,800 |
| 2024/12/27 | 1,475 | 1,489 | 1,472 | 1,486 | +20 | +1.4% | 70,800 |
| 2024/12/26 | 1,456 | 1,466 | 1,455 | 1,466 | +7 | +0.5% | 108,400 |
| 2024/12/25 | 1,469 | 1,469 | 1,448 | 1,459 | +1 | +0.1% | 110,100 |
| 2024/12/24 | 1,453 | 1,471 | 1,448 | 1,458 | +5 | +0.3% | 74,000 |
| 2024/12/23 | 1,449 | 1,453 | 1,440 | 1,453 | +6 | +0.4% | 87,200 |
| 2024/12/20 | 1,446 | 1,453 | 1,438 | 1,447 | +9 | +0.6% | 149,300 |
| 2024/12/19 | 1,446 | 1,459 | 1,438 | 1,438 | -15 | -1% | 76,700 |
| 2024/12/18 | 1,446 | 1,464 | 1,444 | 1,453 | +7 | +0.5% | 57,000 |
| 2024/12/17 | 1,452 | 1,464 | 1,444 | 1,446 | -6 | -0.4% | 87,100 |
| 2024/12/16 | 1,453 | 1,466 | 1,452 | 1,452 | -1 | -0.1% | 89,100 |
| 2024/12/13 | 1,454 | 1,469 | 1,449 | 1,453 | -16 | -1.1% | 143,800 |
| 2024/12/12 | 1,473 | 1,478 | 1,469 | 1,469 | -3 | -0.2% | 121,700 |
| 2024/12/11 | 1,480 | 1,483 | 1,471 | 1,472 | -8 | -0.5% | 99,300 |
| 2024/12/10 | 1,483 | 1,485 | 1,477 | 1,480 | -3 | -0.2% | 49,000 |
| 2024/12/09 | 1,490 | 1,500 | 1,483 | 1,483 | +3 | +0.2% | 156,000 |
| 2024/12/06 | 1,475 | 1,480 | 1,471 | 1,480 | +6 | +0.4% | 87,100 |
| 2024/12/05 | 1,477 | 1,484 | 1,470 | 1,474 | -3 | -0.2% | 53,800 |
| 2024/12/04 | 1,485 | 1,489 | 1,477 | 1,477 | -9 | -0.6% | 53,300 |
| 2024/12/03 | 1,468 | 1,498 | 1,468 | 1,486 | +14 | +1% | 87,200 |
| 2024/12/02 | 1,470 | 1,475 | 1,467 | 1,472 | +4 | +0.3% | 52,400 |
| 2024/11/29 | 1,480 | 1,490 | 1,468 | 1,468 | -17 | -1.1% | 101,700 |
101～
150
件表示中 / 3740件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 杏林製薬 | 150,000円 | -2.4% | -52.3% | 3.80% | 17.95倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ゼリア新薬 | 205,100円 | +3.1% | -6.5% | 2.34% | 9.52倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 持田薬 | 290,800円 | +5.1% | -7.0% | 2.75% | 19.09倍 | 0.79倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ネクセラファーマ | 88,200円 | +20.3% | - | 0.00% | 156.38倍 | 1.16倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ＪＣＲファーマ | 61,400円 | +14.3% | - | 3.26% | 24.94倍 | 1.59倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム
